Phase III trial of sarilumab in Covid-19 patients requiring mechanical ventilation fails to meet primary and key secondary endpoints

The placebo-controlled trial, which has now been stopped, was evaluating the addition of sarilumab to best supportive care. Although minor positive trends were noted in critical patients who were mechanically ventilated at baseline, they did not reach statistical significance.


Biospace Inc.